Acurx Pharmaceuticals (NASDAQ:ACXP) Stock Price Down 0.3%

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP – Get Rating)’s share price traded down 0.3% on Tuesday . The stock traded as low as $3.51 and last traded at $3.63. 6,462 shares changed hands during trading, a decline of 73% from the average session volume of 23,630 shares. The stock had previously closed at $3.64.

The stock has a market capitalization of $37.25 million and a P/E ratio of -2.39. The company’s 50 day simple moving average is $3.29 and its two-hundred day simple moving average is $3.76.

Acurx Pharmaceuticals (NASDAQ:ACXP – Get Rating) last issued its quarterly earnings data on Tuesday, May 10th. The company reported ($0.26) earnings per share for the quarter, topping the consensus estimate of ($0.33) by $0.07.

Several institutional investors and hedge funds have recently added to or reduced their stakes in ACXP. BlackRock Inc. bought a new stake in shares of Acurx Pharmaceuticals during the third quarter valued at approximately $33,000. Millennium Management LLC bought a new stake in shares of Acurx Pharmaceuticals during the third quarter valued at approximately $155,000. Finally, Patriot Financial Group Insurance Agency LLC grew its stake in shares of Acurx Pharmaceuticals by 75.0% during the fourth quarter. Patriot Financial Group Insurance Agency LLC now owns 7,000 shares of the company’s stock valued at $30,000 after purchasing an additional 3,000 shares during the last quarter. 0.72% of the stock is currently owned by institutional investors and hedge funds.

Acurx Pharmaceuticals Company Profile (NASDAQ:ACXP)

Acurx Pharmaceuticals, Inc, a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections.

Featured Stories

• Get a free copy of the StockNews.com research report on Acurx Pharmaceuticals (ACXP)
• Should Silver Stocks Be A Part Of Your Portfolio?
• This Still Isn’t A Buyable Bottom For Stocks 
• ABM Industries, A Clean Play For Dirty Economic Times 
• Don’t Get Too Bullish On Lennar Even Though It’s A Good Buy 
• Dividend-Paying Midstream Oil Companies That Could Help You The Mitigate Market Volatility

Want More Great Investing Ideas?